Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

13.77

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

0.02

EPS Last/This Y

-0.33

EPS This/Next Y

0.52

Price

6.65

Target Price

26.25

Analyst Recom

1.22

Performance Q

-12.73

Relative Volume

0.75

Beta

-1.27

Ticker: DAWN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04DAWN6.80.270.004569
2025-07-07DAWN6.640.270.004562
2025-07-08DAWN6.610.270.004583
2025-07-09DAWN6.990.270.004596
2025-07-10DAWN7.180.270.304643
2025-07-11DAWN6.790.260.004676
2025-07-14DAWN6.930.260.004688
2025-07-15DAWN6.570.261.464690
2025-07-16DAWN6.610.260.004717
2025-07-17DAWN6.510.260.004819
2025-07-18DAWN6.410.250.004953
2025-07-21DAWN6.410.070.002728
2025-07-22DAWN6.580.070.002802
2025-07-23DAWN6.940.070.002858
2025-07-24DAWN7.220.060.133050
2025-07-25DAWN7.240.060.003098
2025-07-28DAWN7.110.060.033123
2025-07-29DAWN6.980.060.003219
2025-07-30DAWN6.860.060.003180
2025-07-31DAWN6.70.070.003143
2025-08-01DAWN6.640.060.103176
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04DAWN6.80-591.0- -1.36
2025-07-07DAWN6.64-591.0- -1.36
2025-07-08DAWN6.61-591.0- -1.36
2025-07-09DAWN7.00-591.0- -1.36
2025-07-10DAWN7.19-591.0- -1.36
2025-07-11DAWN6.79-591.0- -1.36
2025-07-14DAWN6.93-591.0- -1.36
2025-07-15DAWN6.57-591.0- -1.36
2025-07-16DAWN6.61-591.0- -1.36
2025-07-17DAWN6.50-591.0- -1.36
2025-07-18DAWN6.41-591.0- -1.36
2025-07-21DAWN6.40-591.0- -1.36
2025-07-22DAWN6.58-591.0- -1.36
2025-07-23DAWN6.94-591.0- -1.36
2025-07-24DAWN7.21-591.0- -1.36
2025-07-25DAWN7.23-591.0- -1.35
2025-07-28DAWN7.19-586.1- -1.35
2025-07-29DAWN6.99-586.1- -1.35
2025-07-30DAWN6.87-586.1- -1.35
2025-07-31DAWN6.71-586.1- -1.35
2025-08-01DAWN6.65-586.1- -1.35
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04DAWN-0.180.3516.89
2025-07-07DAWN-0.180.3516.89
2025-07-08DAWN-0.180.3516.89
2025-07-09DAWN-0.180.3516.89
2025-07-10DAWN-0.180.3516.89
2025-07-11DAWN-0.180.3515.66
2025-07-14DAWN-0.180.4315.66
2025-07-15DAWN-0.180.4315.66
2025-07-16DAWN-0.180.4315.66
2025-07-17DAWN-0.180.4315.66
2025-07-18DAWN-0.180.4315.66
2025-07-21DAWN-0.180.3815.66
2025-07-22DAWN-0.180.3815.66
2025-07-23DAWN-0.180.3815.66
2025-07-24DAWN-0.180.3815.66
2025-07-25DAWN-0.180.3813.77
2025-07-28DAWN-0.18-1.3713.77
2025-07-29DAWN-0.18-1.3713.77
2025-07-30DAWN-0.18-1.3713.77
2025-07-31DAWN-0.18-1.3713.77
2025-08-01DAWN-0.18-1.3713.77
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.35

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.33

Insider Transactions

-0.18

Institutional Transactions

-1.37

Beta

-1.27

Average Sales Estimate Current Quarter

35

Average Sales Estimate Next Quarter

39

Fair Value

Quality Score

44

Growth Score

29

Sentiment Score

30

Actual DrawDown %

76.8

Max Drawdown 5-Year %

Target Price

26.25

P/E

Forward P/E

PEG

P/S

4.16

P/B

1.41

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y​

-1.35

EPS Next Y. (Est.)

-0.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-42.66

Relative Volume

0.75

Return on Equity vs Sector %

-38.1

Return on Equity vs Industry %

-19.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Day One Biopharmaceuticals, Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 181
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading